MMR: patient group direction (PGD) template
PGD template to support the national MMR vaccination programme.
Applies to England
Documents
Details
This patient group direction (PGD) template supports the administration of measles, mumps and rubella (MMR) vaccine, to individuals born on or before 31 December 2019 requiring opportunistic catch up for routine immunisation, or for travel to endemic areas or measles outbreak management.
The MMR PGD may be used by those 6 to 12 months of age at time of presentation if early MMR protection is required, such as for travel or measles outbreak.
MMR vaccine PGD version 7.0 is valid from 1 January 2026 to 30 November 2028.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy and procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.
Updates to this page
-
Added version 7.0, see page 3 for change history.
-
Added version 6.0, see page 2 for change history.
-
Added version 5, see page 2 for change history.
-
Added version 4 (see page 2 for change history).
-
Added V03.00 - routine review.
-
Routine PGD update on expiry of v01.00.
-
First published.